Current Problems in Cardiology
Volume 34, Issue 12 , Pages 586-662 , December 2009

Adding an Electrocardiogram to the Pre-participation Examination in Competitive Athletes: A Systematic Review

References 

  1. Corrado D, Pelliccia A, Bjornstad HH, et al. Pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol (Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and The Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology). G Eur Heart J. 2005;26(5):516–524
  2. Maron BJ, Douglas PS, Graham TP, et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol. 2005;45(8):1322–1326
  3. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity and Metabolism: endorsed by the American College of Cardiology foundation. Circulation. 2007;115(12):1643–1655
  4. Chaitman BR. An ECG should not be included in routine preparticipation screening of young athletes. Circulation. 2007;116(22):2610–2614
  5. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med. 1998;339(6):364–369
  6. Eckart RE, Scoville SL, Campbell CL, et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med. 2004;141(11):829–834
  7. Corrado D, Basso C, Thiene G. SCD in young people with apparently normal heart. Cardiovasc Res. 2001;50(2):399–408
  8. Maron BJ, Gohman TE, Aeppli D. Prevalence of SCD during competitive sports activities in Minnesota high school athletes. J Am Coll Cardiol. 1998;32(7):1881–1884
  9. Basavarajaiah S, Shah A, Sharma S. Sudden cardiac death in young athletes. Heart. 2007;93(3):287–289
  10. Corrado D, Basso C, Schiavon M, et al. Does sports activity enhance the risk of SCD?. J Cardiovasc Med. 2006;7(4):228–233
  11. Maron BJ. The paradox of exercise. N Engl J Med. 2000;343:1409–1411
  12. Curfman GD. The health benefits of exercise (A critical reappraisal). N Engl J Med. 1993;328:574–576
  13. Curfman GD. Is exercise beneficial—or hazardous—to your heart?. N Engl J Med. 1993;239:1730–1731
  14. Thompson PD, Funk EJ, Carleton RA, et al. Incidence of death during jogging in Rhode Island from 1975 through 1980. J Am Med Assoc. 1982;247:2535–2538
  15. Siscovick DS, Weiss NS, Fletcher RH, et al. The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med. 1984;311:874–877
  16. Willich SN, Lewis M, Lowel H, et al. Physical exertion as a trigger of acute myocardial infarction (Triggers and Mechanisms of Myocardial Infarction Study Group). N Engl J Med. 1993;329:1684–1690
  17. Mittleman MA, Maclure M, Tofler GH, et al. Determinants of Myocardial Infarction Onset Study Investigators Triggering of acute myocardial infarction by heavy physical exertion (Protection against triggering by regular exertion). N Engl J Med. 1993;329:1677–1683
  18. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol. 2003;42(11):1959–1963
  19. Corrado D, Thiene G, Nava A, et al. Sudden death in young competitive athletes: clinico-pathologic correlations in 22 cases. Am J Med. 1990;89:588–596
  20. Basso C, Thiene G, Corrado D, et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol. 2000;31:988–998
  21. Corrado D, Fontaine G, Marcus FI, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (Need for an international registry). Circulation. 2000;101:e101
  22. Corrado D, Basso C, Poletti A, et al. SCD in the young: is coronary thrombosis the major precipitating factor?. Circulation. 1994;90:2315–2323
  23. Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes (Clinical, demographics, and pathological profiles). J Am Med Assoc. 1996;276:199–204
  24. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm. 2005;2(4):429–440
  25. Miyasaka Y, Tsuji H, Yamada K, et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol. 2001;38:771–774
  26. Yoshinaga M, Anan R, Nomura Y, et al. Prevalence and time of appearance of Brugada electrocardiographic pattern in young male adolescents from a three-year follow-up study. Am J Cardiol. 2004;94(9):1186–1189
  27. Sudden, unexpected, nocturnal deaths among Southeast Asian refugees. MMWR. Morb Mortal Wkly Rep. 1981;30:581–584589
  28. Junttila MJ, Raatikainen MJ, Karjalainen J, et al. Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population. Eur Heart J. 2004;25(10):874–878
  29. Lee C, Soni A, Tate RB, et al. The incidence and prognosis of Brugada ECG pattern in the Manitoba follow-up study. Can J Cardiol. 2005;21(14):1286–1290
  30. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111(3):257–263
  31. Pérez Riera AR, Antzelevitch C, Schapacknik E, et al. Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia?. J Electrocardiol. 2005;38(3):260–263
  32. Di Diego JM, Fish JM, Antzelevitch C. Brugada syndrome and ischemia-induced ST-segment elevation (Similarities and differences). J Electrocardiol. 2005;38(suppl):14–17(4)
  33. Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern to the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J. 1999;20(6):465–470
  34. Corrado D, Basso C, Buja G, et al. Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation. 2001;103(5):710–717
  35. Kapetanopoulos A, Kluger J, Maron BJ, et al. The congenital long QT syndrome and implications for young athletes. Med Sci Sports Exerc. 2006;38(5):816–825
  36. Vetter VL. Clues or miscues? (How to make the right interpretation and correctly diagnose long-QT syndrome). Circulation. 2007;115(20):2595–2598
  37. Taggart NW, Haglund CM, Tester DJ, et al. Diagnostic miscues in congenital long-QT syndrome. Circulation. 2007;115(20):2613–2620
  38. Pelliccia A, Culasso F, Di PFM, et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J. 2007;28(16):2006–2010
  39. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence and significance of an isolated long QT interval in elite athletes. Eur Heart J. 2007;28(23):2944–2949
  40. Turkmen M, Barutcu I, Esen AM, et al. Assessment of QT interval duration and dispersion in athlete's heart. J Int Med Res. 2004;32(6):626–632
  41. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103(1):89–95
  42. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary (A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)). J Am Coll Cardiol. 2006;48(5):1064–1108
  43. Wolff L, Parkinson J, White P. Bundle branch block with short PR interval in healthy young people prone to paroxysmal tachycardia. Am Heart J. 1930;5:685–704
  44. Colavita D, Packer J, Pressley K, et al. Frequency, diagnosis and clinical characteristics of patients with multiple accessory atrioventricular pathways. Am J Cardiol. 1987;59(6):601–606
  45. Basso C, Corrado D, Rossi L, et al. Ventricular preexcitation in children and young adults: atrial myocarditis as a possible trigger of SCD. Circulation. 2001;103(2):269–275
  46. Sarubbi B, Scognamiglio G, Limongelli G, et al. Asymptomatic ventricular pre-excitation in children and adolescents: a 15 year follow up study. Heart. 2003;89(2):215–217
  47. Klein GJ, Yee R, Sharma AD. Longitudinal electrophysiological assessment of asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med. 1989;320:1229–1233
  48. Krahn AD, Mandfreda J, Tate RB, et al. The natural history of electrocardiographic prereexcitation in men (The Manitoba follow-up study). Ann Intern Med. 1992;116:456–460
  49. Sharma AD, Klein GJ, Guiraudon GM, et al. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation. 1985;72:161–169
  50. Robinson K, Rowland E, Krikler DM. Wolff-Parkinson-White syndrome: atrial fibrillation as the presenting arrhythmia. Br Heart J. 1988;59:578–580
  51. Pietersen AH, Andersen ED, Sandoe E. Atrial fibrillation in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1992;70:38–43A
  52. Munger TM, Packer DL, Hammill SC, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota, 1953-89. Circulation. 1993;87(3):866–873
  53. Goudevenos JA, Katsouras CS, Graekas G, et al. Ventricular pre-excitation in the general population: a study on the mode of presentation and clinical course. Heart. 2000;83(1):29–34
  54. Fitzsimmons PJ, McWhirter PD, Peterson DW, et al. The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. Am Heart J. 2001;142(3):530–536
  55. Timmermans C, Smeets J, Rodriguez LM, et al. Aborted SCD in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492–494
  56. Klein GJ, Prystowsky EN, Yee R, et al. Asymptomatic Wolff-Parkinson-White (Should we intervene?). Circulation. 1989;80:1902–1905
  57. Klein GJ, Bashore TM, Sellers TD, et al. Ventricular fibrillation in the Wolff-Parkinson-White's syndrome. N Engl J Med. 1979;301:1080–1085
  58. Montoya PT, Brugada P, Smeets J, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J. 1991;12:144–150
  59. Pappone C, Santinelli V, Rosanio S, et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. J Am Coll Cardiol. 2003;41(2):239–244
  60. Attoyan C, Haissaguerre M, Dartigues JF, et al. Ventricular fibrillation in Wolff-Parkinson-White syndrome (Predictive factors). Arch Mal Coeur Vaiss. 1994;87(7):889–897
  61. Lee PC, Hwang B, Tai CT, et al. The different electrophysiological characteristics in children with Wolff-Parkinson-White syndrome between those with and without atrial fibrillation. Pacing Clin Electrophysiol. 2004;27(2):235–239
  62. Bromberg BI, Lindsay BD, Cain ME, et al. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce SCD among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1996;27(3):690–695
  63. Sharma AD, Yee R, Guiraudon G, et al. Sensitivity and specificity of invasive and noninvasive testing for risk of SCD in Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1987;10(2):373–381
  64. Klein GJ, Gulamhusein SS. Intermittent preexcitation in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1983;52(3):292–296
  65. Bille K, Figueiras D, Schamasch P, et al. SCD in athletes: the Lausanne Recommendations. Eur J Cardiovasc Prev Rehabil. 2006;13(6):859–875
  66. Sarubbi B. The Wolff-Parkinson-White electrocardiogram pattern in athletes: how and when to evaluate the risk for dangerous arrhythmias (The opinion of the paediatric cardiologist). J Cardiovasc Med. 2006;7(4):271–278
  67. Link MS, Homoud MK, Wang PJ. Cardiac arrhythmias in the athlete. Cardiol Rev. 2001;9(1):21–30
  68. Coumel P. Autonomic influences in atrial tachyarrhythmias (Vagal influences that are marked in athletes predispose some athletes to certain types of atrial tachycardias and AF). J Cardiovasc Electrophysiol. 1996;7:999–1007
  69. Furlanello F, Bertoldi A, Dallago M, et al. Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol. 1998;9(suppl):S63–S68(8)
  70. Mont L, Sambola A, Brugada J, et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J. 2002;23(6):477–482
  71. Pelliccia A, Maron BJ, Di PFM, et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005;46(4):690–696
  72. Hoogsteen J, Schep G, Van Hemel NM, et al. Paroxysmal atrial fibrillation in male endurance athletes (A 9-year follow up). Europace. 2004;6(3):222–228
  73. Baldesberger S, Bauersfeld U, Candinas R, et al. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J. 2008;29(1):71–78
  74. Adabag A, Selcuk A, Maron BJ. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol. 2007;12(2):171–180
  75. Pelliccia A. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J. 2006;27(18):2196–2200
  76. Basavarajaiah S, Shah A, Sharma S. Sudden cardiac death in young athletes. Heart. 2007;93(3):287–289
  77. Basavarajaiah S, Wilson M, Whyte G, et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening. JACC. 2008;51(10):1033–1039
  78. Dollar AL, Roberts WC. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy. Am J Med. 1989;87(4):377–381
  79. Maron BJ, Carney KP, Lever HM, et al. Relationship of race to SCD in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41(6):974–980
  80. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365–373
  81. Zipes D, Camm A, Borggrefe M, et al. Ventricular arrhythmias and the prevention of sudden cardiac death. (Writing Committee to Develop guidelines for management of patients with the European Society of Cardiology Committee for Practice Guidelines American College of Cardiology/American Heart Association Task Force and Arrhythmias and the Prevention of Sudden Cardiac Death). A report of the ACC/AHA/ESC 2006 guidelines for management of patients with ventricular. J Am Coll Cardiol. 2006;48:247–346
  82. Maron BJ, Estes NA, Maron MS, et al. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 2003;107:2872–2875
  83. Maron B, Maron M, Lesser J, et al. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol. 2008;101(4):544–547
  84. Ostman-Smith I, Wettrell G, Keeton B, et al. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young. 2005;15(6):632–642
  85. Montgomery JV, Harris KM, Casey SA, et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2005;96(2):270–275
  86. Pelliccia F, Cianfrocca C, Cristofani R, et al. ECG findings in patients with hypertrophic cardiomyopathy (Relation to presenting features and prognosis). J Electrocardiol. 1990;23(3):213–222
  87. Bongioanni S, Bianchi F, Migliardi A, et al. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol. 2007;100(3):503–506
  88. Yi G, Elliott P, McKenna WJ, et al. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. Am J Cardiol. 1998;82(12):1514–1519
  89. Pelliccia A, Fernando M, Di Paolo M, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358:152–161
  90. Dumont CA, Monserrat L, Soler R, et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J. 2006;27(14):1725–1731
  91. Maron BJ, Zipes D 36th Bethesda Conference. Eligibility recommendations for competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2005;45(8):1340–1341
  92. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982;65:384–398
  93. Danieli GA, Rampazzo A. Genetics of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol. 2002;17(3):218–221
  94. Nasir K, Bomma C, Tandri H, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation. 2004;110(12):1527–1534
  95. Marcus FI. Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am J Cardiol. 2005;95(9):1070–1071
  96. Gemayel C, Pelliccia A, Thompson PD. Arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2001;38(7):1773–1781
  97. Furlanello F, Bertoldi A, Dallago M, et al. Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol. 1998;21:331–335
  98. Hulot JS, Jouven X, Empana JP, et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. 2004;110:1879–1884
  99. Kirchhof P, Fabritz L, Zwiener M, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation. 2006;114:1799–1806
  100. Daubert C, Vauthier M, Carré F, et al. Influence of exercise and sport activity on functional symptoms and ventricular arrhythmias in arrhythmogenic right ventricular disease. [Abstract] J Am Coll Cardiol. 1994;23(suppl):34A
  101. Maron BJ, Bodison SA, Wesley YE, et al. Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease. J Am Coll Cardiol. 1987;10(6):1214–1221
  102. Choo JK, Abernethy WB, Hutter AM. Electrocardiographic observations in professional football players. Am J Cardiol. 2002;90(2):198–200
  103. Fuller CM, McNulty CM, Spring DA, et al. Prospective screening of 5,615 high school athletes for risk of SCD. Med Sci Sports Exerc. 1997;29(9):1131–1138
  104. Sharma S, Whyte G, Elliott P, et al. Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med. 1999;33(5):319–324
  105. Wilson MG, Basavarajaiah S, Whyte G, et al. Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies? (The role of electrocardiography). Br J Sports Med. 2008;42(3):207–211
  106. Tanaka Y, Yoshinaga M, Anan R, et al. Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Med Sci Sports Exerc. 2006;38:2–6
  107. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. J Am Med Assoc. 2006;296(13):1593–1601
  108. Bjornstad H, Storstein L, Meen HD, et al. Electrocardiographic findings in athletic students and sedentary controls. Cardiology. 1991;79(4):290–305
  109. Bjørnstad H, Storstein L, Dye Meen H, et al. ECG findings of heart rate and conduction times in athletic students and sedentary control subjects. Cardiology. 1993;83(4):258–267
  110. Bjornstad H, Smith G, Storstein L, et al. Electrocardiographic and echocardiographic findings in top athletes, athletic students and sedentary controls. Cardiology. 1993;82(1):66–74
  111. Langdeau JB, Blier L, Turcotte H, et al. Electrocardiographic findings in athletes: the prevalence of left ventricular hypertrophy and conduction defects. Can J Cardiol. 2001;17(6):655–659
  112. Turkmen M, Barutcu I, Esen AM, et al. Assessment of QT interval duration and dispersion in athlete's heart. J Int Med Res. 2004;32(6):626–632
  113. Bjornstad H, Storstein L, Dye Meen H, et al. Electrocardiographic findings according to level of fitness and sport activity. Cardiology. 1993;83(4):268–279
  114. Pelliccia A, Maron BJ, Culasso F, et al. Clinical Signficance of abnormal electrocardiographic pattern in trained athletes. Circulation. 2000;102:278–284
  115. Roeske WR, O'Rourke RA, Klein A, et al. Noninvasive evaluation of ventricular hypertrophy in professional athletes. Circulation. 1976;53(2):286–291
  116. Mumford M, Prakash R. Electrocardiographic and echocardiographic characteristics of long distance runners (Comparison of left ventricular function with age- and sex-matched controls). Am J Sports Med. 1981;9(1):23–28
  117. Zakynthinos E, Vassilakopoulos T, Mavrommati I, et al. Echocardiographic and ambulatory electrocardiographic findings in elite water-polo athletes. Scand J Med Sci Sports. 2001;11(3):149–155
  118. Storstein L, Bjornstad H, Hals O, et al. Electrocardiographic findings according to sex in athletes and controls. Cardiology. 1991;79(3):227–236
  119. George KP, Wolfe LA, Burggraf GW, et al. Electrocardiographic and echocardiographic characteristics of female athletes. Med Sci Sports Exerc. 1995;27(10):1362–1370
  120. Moroe K, Kimoto K, Inoue T, et al. Evaluation of abnormal signal-averaged electrocardiograms in young athletes. Jpn Circul J. 1995;59(5):247–256
  121. Lonati LM, Magnaghi G, Bizzi C, et al. Patterns of QT dispersion in athletic and hypertensive left ventricular hypertrophy. Ann Noninvasive Electrocardiol. 2004;9(3):252–256
  122. Huston TP, Puffer JC, Rodney WM. The athletic heart syndrome. N Engl J Med. 1985;313:24
  123. Douglas PS, O'Toole ML, Hiller WD, et al. Echocardiographic and ECG findings in athletes. Am Heart J. 1988;116(3):784–790
  124. Pelliccia A, Di PFM, Maron BJ. The athlete's heart: remodeling, electrocardiogram and preparticipation screening. Cardiol Rev. 2002;10(2):85–90
  125. Björnstad H, Storstein L, Meen HD, et al. Electrocardiographic findings of left, right and septal hypertrophy in athletic students and sedentary controls. Cardiology. 1993;82(1):56–65
  126. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085–1092
  127. Corrado D, Basso C, Schiavon M, et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol. 2008;52:1981–1989

PII: S0146-2806(09)00114-5

doi: 10.1016/j.cpcardiol.2009.08.002

Current Problems in Cardiology
Volume 34, Issue 12 , Pages 586-662 , December 2009

Article Tools

* Image Usage & Resolution